Technology Licensing and Intellectual Property Issues

Prem Das, Dana-Farber Cancer Institute (Co-Chair)
Alan Jakimo, Sidley Austin LLP
Jeb Keiper, GlaxoSmithKline
Lita Nelsen, MIT (Co-Chair)
Frances Toneguzzo, Massachusetts General Hospital
Teri Willey, Mount Sinai Medical Center

Specific Questions to be Addressed

  • How do megafunds work with universities, academic medical centers, the biopharma industry, and insurers?
  • Can we create a technology licensing template to facilitate innovation and funding?
  • How can we align the interests of various stakeholders to maximize value and minimize conflicts of interest?